To understand the relationship between Notch and BCR-ABL, we used inhibitors of both Notch and ABL signalling and found that the Notch and BCR-ABL pathways antagonise each other in primary CD34+ cells isolated from chronic phase CML as well as in cell line models. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.